KEGG   DRUG: D08896Help
Entry
D08896                      Drug                                   

Name
Dacetuzumab (USAN)
Formula
C6452H9964N1732O1998S42
Exact mass
145019.9592
Mol weight
145109.2862
Sequence
  Type
Peptide
Activity
Treatment of CD40-positive cancers
Comment
Monoclonal antibody
Target
CD40 [HSA:958] [KO:K03160]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04514  Cell adhesion molecules (CAMs)  
 
Brite
Target-based classification of drugs [BR:br08310]
 Cytokine receptors
  TNF receptor family
   TNFRSF5 (CD40)
    Dacetuzumab
     D08896  Dacetuzumab (USAN)
BRITE hierarchy
Other DBs
CAS: 
880486-59-9
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system